About TI Health
TI Health is a healthcare data marketing and predictive analytics company. It specializes in early signal and event targeting using diagnostic data, diagnosis, distribution, claims, and formulary market access information. It delivers omnichannel health care provider (HCP) engagement insights and activation solutions for pharmaceutical and life sciences brands. The company was formerly known as SRAXmd. The company was founded in 2010 and is based in New York, New York. In March 2023, TI Health was acquired by Real Chemistry. The terms of the transaction were not disclosed.
Research containing TI Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned TI Health in 1 CB Insights research brief, most recently on Jul 7, 2021.
Latest TI Health News
Mar 2, 2023
Share Advertising technology company will be integrated into Swoop, creating a unified HCP and DTC system of engagement for healthcare marketers Growth expands Real Chemistry’s capabilities and technology offerings Real Chemistry , the leading provider of AI-driven insights and human-centric experiences for the healthcare industry, announced the acquisition of TI Health, a data-driven marketing and predictive analytics company that delivers omnichannel health care provider (HCP) engagement insights and activation solutions for pharmaceutical and life sciences brands. TI Health will be integrated into Swoop, which is part of Real Chemistry and is the leading provider of exclusive privacy-safe patient audiences, creating a fully unified HCP and direct-to-consumer (DTC) system of engagement for healthcare marketers. “Reaching HCPs has become more difficult than ever with the decline of face-to-face engagement and the oversaturation of non-personal promotion” “Historically, HCP and DTC advertising have functioned independently, engaging physicians and patients separately despite a common objective of increasing awareness of new therapies designed to improve health,” said Scott Rines , President, Swoop. “This has led to wasted budgets, unoptimized activation and suboptimal script lift. With the combination of TI Health’s best-in-class HCP targeting and activation with Swoop’s highly precise patient audiences, brands can now coordinate engagement with their ideal patient and HCP audiences, driving greater Rx lift and delivering sustained benefits to patients.” In conjunction with the acquisition, Swoop is launching four new solutions built by connecting its system of engagement with the TI Health Affiniti™ insights platform, which includes content, message and channel affinity data for more than 1.6 million HCPs. Affiniti draws on more than 500 million observed national provider identifier (NPI) exposures and engagements. HCP Programmatic Activation: Demand-side platforms (DSP) – agnostic, this is the only self-serve HCP programmatic solution with physician level detail reporting. Marketers can engage HCPs based on individual media preferences and incorporate time-sensitive triggers using diagnosis, affiliation, payer and prescribing behavior. HCP Social Media Engagement: Marketers can apply the same ideal HCP audience used for programmatic advertising to self-serve on social media, engaging verified HCPs, including key opinion leaders and influencers, on the most popular networks such as Facebook, Twitter, Instagram and TikTok. HCP TV Planning and Activation: This is the first HCP TV advertising solution scaled across addressable TV and connected TV/over-the-top to reach verified NPI households. Advertisers can apply the same audience used in digital channels for TV planning and activation to optimize reach and frequency. HCP Targeting with Hospital/IDN Affiliation and Payer Data: This provider-based targeting and top decile targeting of HCPs seeing patients with specific payer coverage delivers further audience refinement beyond diagnosis and prescribing behavior. “Reaching HCPs has become more difficult than ever with the decline of face-to-face engagement and the oversaturation of non-personal promotion,” said TI Health Founder and CEO Erin DeRuggiero. “Personalized omni-channel for HCPs, based on their affinity for specific content, messaging and channels, allows healthcare marketers to break through the noise in the moments that matter and meet HCPs where they are, establishing their brand as the therapy of choice. Joining Swoop allows us to accelerate the innovation and scale of our machine learning and AI-powered audience expansion and activation capabilities. When HCP and DTC engagement works in tandem in clinical, endemic and non-endemic environments, advertisers, healthcare professionals and patients will all benefit.”
TI Health Frequently Asked Questions (FAQ)
When was TI Health founded?
TI Health was founded in 2010.
Where is TI Health's headquarters?
TI Health's headquarters is located at 10 West 37th Street, New York.
What is TI Health's latest funding round?
TI Health's latest funding round is Acquired.
Who are the investors of TI Health?
Investors of TI Health include Real Chemistry.
Who are TI Health's competitors?
Competitors of TI Health include HealthVerity and 1 more.
Compare TI Health to Competitors
Prognos Health provides a healthcare analytics platform. The platform stores and processes clinical lab test data to help pharma, payers, and diagnostics companies predict disease to drive earlier intervention. The company was founded in 2010 and is based in New York, New York.
Verato provides software-as-a-service solutions. The company offers data management, identity analytics, integrations, and more. It serves healthcare providers, government, health information exchange, and other sectors. It was formerly known as Araxid. The company was founded in 2012 and is based in McLean, Virginia.
HealthVerity provides technologies and software tools for the discovery and integration of optimal patient data sets. It offers a healthcare data and patient informatics platform designed to offer enhanced data discovery and distribution. It works with pharmaceuticals and hospitals to increase the insights from data supplier relationships. The company was founded in 2014 and is based in Philadelphia, Pennsylvania.
Syntropy is a company that focuses on the biomedical data sector, providing solutions for data curation and collaboration. The company offers services to healthcare organizations, helping them to integrate and harmonize complex data sets, and facilitating collaboration within and across organizations. Syntropy primarily serves the healthcare, life sciences, and government sectors. It is based in Boston, Massachusetts.
Luna offers a health and genomic data platform owned by its community of personal health information donors. It empowers individuals to share their health data for medical research and the greater good of the community. The company was founded in 2017 and is based in San Diego, California.
Seqster is a healthcare technology company that focuses on breaking down health data silos. It operates in the healthcare and life sciences industries. The company's main service is an enterprise operating system that aggregates disparate health data sources into a single, comprehensive view of a patient in real-time. This includes data from electronic health records, genomic DNA, wearables, pharmacy, and social determinants of health. Seqster primarily sells to the life sciences industry and the healthcare sector. It was founded in 2016 and is based in San Diego, California.